Rozek Elizabeth 4
4 · Sagimet Biosciences Inc. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
Rozek Elizabeth
Chief Legal & Admin. Officer
Transactions
- Sale
Series A Common Stock
2024-07-19$3.10/sh−10,914$33,830→ 160,506 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.